Non-canonical fibroblast growth factor signalling in angiogenesis
- PMID: 18056763
- DOI: 10.1093/cvr/cvm086
Non-canonical fibroblast growth factor signalling in angiogenesis
Abstract
Whereas fibroblast growth factors (FGFs) classically transmit their signals via high-affinity tyrosine kinase receptors (FGFR1-4), recent evidence strongly implicates non-tyrosine kinase receptors (NTKR) or cell-surface FGFR-interacting proteins as important players in FGF signalling. Although NTKR have lower affinity for FGFs in comparison with cognate tyrosine kinase receptors, because of their high abundance they can effectively bind FGFs and produce unique biological effects independent of FGFRs. A prime example of such NTKR is the syndecan family of plasma membrane proteoglycans and, in particular, syndecan-4, which transmits FGF signalling via a protein kinase Calpha pathway. Another NTKR, alpha(v)beta(3) integrin, functions as an FGF signalling modulator by binding both FGF2 and FGFR1. Yet another NTKR, neural cell adhesion molecule (NCAM), can serve as an FGFR ligand and assemble an FGFR signalling complex in the absence of FGFs. Furthermore, N-cadherin, which has been reported to associate with FGFR, appears to activate FGFR in both ligand (FGF)-dependent and ligand-independent manners. Finally, gangliosides are implicated as a co-receptor system of FGFs. The biological consequence of non-canonical FGF signalling tends to be less discernable compared to the canonical FGFR activation because of the overlap between these two pathways; nevertheless, non-canonical signalling is important and sometimes essential for cellular functions. Given the diversity of FGF activities through embryonic development to adult physiology, the existence of the non-canonical signalling system may account for the different cellular response to the FGF input in different biological contexts. In this review, we will discuss recent findings related to non-canonical FGF signalling with emphasis on the endothelial biology and angiogenesis.
Similar articles
-
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic _target in tumor angiogenesis.Expert Opin Ther _targets. 2015;19(10):1361-77. doi: 10.1517/14728222.2015.1062475. Epub 2015 Jun 30. Expert Opin Ther _targets. 2015. PMID: 26125971 Review.
-
Glycosylation of FGF/FGFR: An underrated sweet code regulating cellular signaling programs.Cytokine Growth Factor Rev. 2024 Jun;77:39-55. doi: 10.1016/j.cytogfr.2024.04.001. Epub 2024 May 3. Cytokine Growth Factor Rev. 2024. PMID: 38719671 Review.
-
Identification of residues important both for primary receptor binding and specificity in fibroblast growth factor-7.J Biol Chem. 2000 Nov 10;275(45):34881-6. doi: 10.1074/jbc.M003293200. J Biol Chem. 2000. PMID: 10950949
-
FGF signalling through RAS/MAPK and PI3K pathways regulates cell movement and gene expression in the chicken primitive streak without affecting E-cadherin expression.BMC Dev Biol. 2011 Mar 21;11:20. doi: 10.1186/1471-213X-11-20. BMC Dev Biol. 2011. PMID: 21418646 Free PMC article.
-
Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly.Biochemistry. 2004 Apr 27;43(16):4724-30. doi: 10.1021/bi0352320. Biochemistry. 2004. PMID: 15096041
Cited by
-
A place for precision medicine in bladder cancer: _targeting the FGFRs.Future Oncol. 2016 Oct;12(19):2243-63. doi: 10.2217/fon-2016-0042. Epub 2016 Jul 6. Future Oncol. 2016. PMID: 27381494 Free PMC article. Review.
-
Bradykinin B2 Receptor Contributes to Inflammatory Responses in Human Endothelial Cells by the Transactivation of the Fibroblast Growth Factor Receptor FGFR-1.Int J Mol Sci. 2018 Sep 6;19(9):2638. doi: 10.3390/ijms19092638. Int J Mol Sci. 2018. PMID: 30200598 Free PMC article.
-
Expression Pattern and Value of Brain-Derived Neurotrophic Factor in Periodontitis.Int Dent J. 2023 Aug;73(4):542-549. doi: 10.1016/j.identj.2023.03.002. Epub 2023 Mar 28. Int Dent J. 2023. PMID: 36997422 Free PMC article.
-
Suppression of RhoG activity is mediated by a syndecan 4-synectin-RhoGDI1 complex and is reversed by PKCalpha in a Rac1 activation pathway.J Cell Biol. 2009 Jul 13;186(1):75-83. doi: 10.1083/jcb.200810179. Epub 2009 Jul 6. J Cell Biol. 2009. PMID: 19581409 Free PMC article.
-
Indolinones and anilinophthalazines differentially _target VEGF-A- and basic fibroblast growth factor-mediated responses in primary human endothelial cells.Br J Pharmacol. 2012 Jan;165(1):245-59. doi: 10.1111/j.1476-5381.2011.01545.x. Br J Pharmacol. 2012. PMID: 21699503 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous